ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta

Toxicology and Applied Pharmacology

Volumn 232, Issue 2, 2008, Pages 210-217

  Myllynen, Päivi ^a   Kummu, Maria ^a   Kangas, Tiina ^a   Ilves, Mika ^a   Immonen, Elina ^a,b   Rysä, Jaana ^a   Pirilä, Rauna ^a   Lastumäki, Anni ^a   Vähäkangas, Kirsi H ^b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

ABC transporter; ABCG2; PhIP; Placenta; Transfer

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; BREAST CANCER RESISTANCE PROTEIN; CARBON 14; KO 143; MESSENGER RNA; PROBENECID; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL LINE; CHORIOCARCINOMA; CORRELATION ANALYSIS; FETOMATERNAL TRANSFUSION; FETUS CIRCULATION; HUMAN; HUMAN TISSUE; PLACENTAL TRANSFER; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ATP-BINDING CASSETTE TRANSPORTERS; CARCINOGENS; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; FEMALE; FOOD; HUMANS; IMIDAZOLES; MATERNAL-FETAL EXCHANGE; NEOPLASM PROTEINS; PERFUSION; PLACENTA; PREGNANCY;

EID: 52049095040     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.07.006     Document Type: Article

References (61)

1. Audus K.L. Controlling drug delivery across the placenta. Eur. J. Pharm. Sci. 8 (1999) 161-165
2. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat. Res. 464 (2000) 65-76
3. Bennion B.J., Cosman M., Lightstone F.C., Knize M.G., Montgomery J.L., Bennett L.M., Felton J.S., and Kulp K.S. PhIP carcinogenicity in breast cancer: computational and experimental evidence for competitive interactions with human estrogen receptor. Chem. Res. Toxicol. 18 (2005) 1528-1536
4. Bodo A., Bakos E., Szeri F., Varadi A., and Sarkadi B. Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions. J. Biol. Chem. 278 (2003) 23529-23537
5. Brandes J.M., Tavoloni N., Potter B.J., Sarkozi L., Shepard M.D., and Berk P.D. A new recycling technique for human placental cotyledon perfusion: application to studies of the fetomaternal transfer of glucose, inulin, and antipyrine. Am. J. Obstet. Gynecol. 146 (1983) 800-806
6. Brittebo E.B., Karlsson A.A., Skog K.I., and Jägerstad I.M. Transfer of the food mutagen PhIP to foetuses and newborn mice following maternal exposure. Food Chem. Toxicol. 32 (1994) 717-726
7. Ceckova-Novotna M., Pavek P., and Staud F. P-glycoprotein in the placenta: expression, localization, regulation and function. Reprod. Toxicol. 22 (2006) 400-410
8. Crofts F.G., Sutter T.R., and Strickland P.T. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1. Carcinogenesis 19 (1998) 1969-1973
9. Dang Z.C., and Lowik C.W. Removal of serum factors by charcoal treatment promotes adipogenesis via a MAPK-dependent pathway. Mol. Cell. Biochem. 268 (2005) 159-167
10. Dietrich C.G., de Waart D.R., Ottenhoff R., Bootsma A.H., van Gennip A.H., and Elferink R.P. Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo. Carcinogenesis 22 (2001) 805-811
11. Dietrich C.G., de Waart D.R., Ottenhoff R., Schoots I.G., and Elferink R.P. Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats. Mol. Pharmacol. 59 (2001) 974-980
12. Ee P.L., Kamalakaran S., Tonetti D., He X., Ross D.D., and Beck W.T. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res. 64 (2004) 1247-1251
13. Evseenko D., Paxton J.W., and Keelan J.A. Active transport across the human placenta: impact on drug efficacy and toxicity. Expert Opin. Drug. Metab. Toxicol. 2 (2006) 51-69
14. Evseenko D.A., Paxton J.W., and Keelan J.A. The xenobiotic transporter ABCG2 plays a novel role in differentiation of trophoblast-like BeWo cells. Placenta Suppl A (2007) 116-120 2007b
15. Evseenko D.A., Murthi P., Paxton J.W., Reid G., Emerald B.S., Mohankumar K.M., Lobie P.E., Brennecke S.P., Kalionis B., and Keelan J.A. The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction. FASEB J. 21 (2007) 3592-3605
16. Felton J.S., Knize M.G., Bennett L.M., Malfatti M.A., Colvin M.E., and Kulp K.S. Impact of environmental exposures on the mutagenicity/carcinogenicity of heterocyclic amines. Toxicology 198 (2004) 135-145
17. Felton J.S., Knize M.G., Shen N.H., Lewis P.R., Andresen B.D., Happe J., and Hatch F.T. The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 7 (1986) 1081-1086
18. Gluckman P.D., Hanson M.A., and Pinal C. The developmental origins of adult disease. Matern. Child Nutr. 1 (2005) 130-141
19. Hasegawa R., Kimura J., Yaono M., Takahashi S., Kato T., Futakuchi M., Fukutake M., Fukutome K., Wakabayashi K., Sugimura T., Ito N., and Shirai T. Increased risk of mammary carcinoma development following transplacental and trans-breast milk exposure to a food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in Sprague-Dawley rats. Cancer Res. 55 (1995) 4333-4338
20. Heikkilä A., Myllynen P., Keski-Nisula L., Heinonen S., Vähäkangas K., and Ylä-Herttuala S. Gene transfer to human placenta ex vivo: a novel application of dual perfusion of human placental cotyledon. Am. J. Obstet. Gynecol. 186 (2002) 1046-1051
21. Hilakivi-Clarke L., and de Assis S. Fetal origins of breast cancer. Trends Endocrinol. Metab. 17 (2006) 340-341
22. Hitzl M., Schaeffeler E., Hocher B., Slowinski T., Halle H., Eichelbaum M., Kaufmann P., Fritz P., Fromm M.F., and Schwab M. Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1). Pharmacogenetics. 14 (2004) 309-318
23. van Herwaarden A.E., Jonker J.W., Wagenaar E., Brinkhuis R.F., Schellens J.H., Beijnen J.H., and Schinkel A.H. The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res. 63 (2003) 6447-6452
24. Honjo Y., Hrycyna C.A., Yan Q.-W., Medina-Perez W.Y., Robey R.W., van de Laar A., Litman T., Dean M., and Bates S.E. Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res. 61 (2001) 6635-6639
25. Huisman M.T., Smit J.W., Crommentuyn K.M., Zelcer N., Wiltshire H.R., Beijnen J.H., and Schinkel A.H. Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs. AIDS 16 (2002) 2295-2301
26. Imai Y., Ishikawa E., Asada S., and Sugimoto Y. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res. 65 (2005) 596-604
27. Ishikawa T., Hirano H., Onishi Y., Sakurai A., and Tarui S. Functional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structure-activity relationship analyses. Drug Metab. Pharmacokinet. 19 (2004) 1-14
28. Jonker J.W., Smit J.W., Brinkhuis R.F., Maliepaard M., Beijnen J.H., Schellens J.H., and Schinkel A.H. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J. Natl. Cancer Inst. 92 (2000) 1651-1656
29. Klaassen C.D., and Slitt A.L. Regulation of hepatic transporters by xenobiotic receptors. Curr. Drug Metab. 6 (2005) 309-328
30. Kobayashi D., Ieiri I., Hirota T., Takane H., Maegawa S., Kigawa J., Suzuki H., Nanba E., Oshimura M., Terakawa N., Otsubo K., Mine K., and Sugiyama Y. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab. Dispos. 33 (2005) 94-101
31. Lankas G.R., Wise L.D., Cartwright M.E., Pippert T., and Umbenhauer D.R. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod. Toxicol. 12 (1998) 457-463
32. Majalahti-Palviainen T., Hirvinen M., Tervonen V., Ilves M., Ruskoaho H., and Vuolteenaho O. Gene structure of a new cardiac peptide hormone: a model for heart-specific gene expression. Endocrinology. 141 (2000) 731-740
33. 14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans. Carcinogenesis 20 (1999) 705-713
34. Mathias A.A., Hitti J., and Unadkat J.D. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am. J. Physiol.: Regul. Integr. Comp. Physiol. 289 (2005) R963-969
35. Miller M.S. Transplacental lung carcinogenesis: molecular mechanisms and pathogenesis. Toxicol. Appl. Pharmacol. 98 (2004) 95-110
36. Muller C., Laurent G., and Ling V. P-glycoprotein stability is affected by serum deprivation and high cell density in multidrug-resistant cells. J. Cell. Physiol. 163 (1995) 538-544
37. Myllynen P., Kurttila T., Vaskivuo L., and Vähäkangas K. DNA damage caused by benzo(a)pyrene in MCF-7 cells is increased by verapamil, probenecid and PSC833. Toxicol. Lett. 169 (2007) 3-12
38. Myllynen P., Pasanen M., and Vähäkangas K. The fate and effects of xenobiotics in human placenta. Expert Opin. Drug Metab. Toxicol. 3 (2007) 331-346
39. Myllynen P.K., Pienimäki P.K., and Vähäkangas K.H. Transplacental passage of lamotrigine in a human placental perfusion system in vitro and in maternal and cord blood in vivo. Eur. J. Clin. Pharmacol. 58 (2003) 677-682
40. Myllynen P., and Vähäkangas K. An examination of whether human placental perfusion allows accurate prediction of placental drug transport: studies with diazepam. J. Pharmacol. Toxicol. Methods 48 (2002) 131-138
41. Mölsä M., Heikkinen T., Hakkola J., Hakala K., Wallerman O., Wadelius M., Wadelius C., and Laine K. Functional role of P-glycoprotein in the human blood-placental barrier. Clin. Pharmacol. Ther. 78 (2005) 123-131
42. Ozanne S.E., and Constancia M. Mechanisms of disease: the developmental origins of disease and the role of epigenotype. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 539-546
43. Pavek P., Merino G., Wagenaar E., Bolscher E., Novotna M., Jonker J.W., and Schinkel A.H. Human breast cancer resistance protein: interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine. J. Pharmacol. Exp. Ther. 312 (2005) 144-152
44. Pienimäki P., Hartikainen A.L., Arvela P., Partanen T., Herva R., Pelkonen O., and Vähäkangas K. Carbamazepine and its metabolites in human perfused placenta and in maternal and cord blood. Epilepsia 36 (1995) 241-248
45. Schut H.A.J., and Snyderwine E.G. DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis 20 (1999) 353-368
46. Schenker S., Johnson R.F., Mahuren J.D., Henderson G.I., and Coburn S.P. Human placental vitamin B6 (pyridoxal) transport: normal characteristics and effects of ethanol. Am. J. Physiol. 262 (1992) R966-R974
47. Shitara Y., Horie T., and Sugiyama Y. Transporters as a determinant of drug clearance and tissue distribution. Eur. J. Pharm. Sci. 27 (2006) 425-556
48. Sinha R., Gustafson D.R., Kulldorff M., Wen W.Q., Cerhan J.R., and Zheng W. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. J. Natl. Cancer Inst. 92 (2000) 1352-1354
49. Smit J.W., Huisman M.T., van Tellingen O., Wiltshire H.R., and Schinkel A.H. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J. Clin. Invest. 104 (1999) 1441-1447
50. Sugimura T., Wakabayashi K., Nakagama H., and Nagao M. Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish. Cancer Sci. 95 (2004) 290-299
51. Sun M., Kingdom J., Baczyk D., Lye S.J., Matthews S.G., and Gibb W. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 27 (2006) 602-609
52. Syme M.R., Paxton J.W., and Keelan J.A. Drug transfer and metabolism by the human placenta. Clin. Pharmacokinet. 43 (2004) 487-514
53. Tanabe M., Ieiri I., Nagata N., Inoue K., Ito S., Kanamori Y., Takahashi M., Kurata Y., Kigawa J., Higuchi S., Terakawa N., and Otsubo K. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J. Pharmacol. Exp. Ther. 297 (2001) 1137-1143
54. Vähäkangas K., Raunio H., Pasanen M., Sivonen P., Park S.S., Gelboin H.V., and Pelkonen O. Comparison of the formation of benzo[a]pyrene diolepoxide-DNA adducts in vitro by rat and human microsomes: evidence for the involvement of P-450IA1 and P-450IA2. J Biochem Toxicol. 4 (1989) 79-86
55. Wang H., Zhou L., Gupta A., Vethanayagam R.R., Zhang Y., Unadkat J.D., and Mao Q. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. Am. J. Physiol. Endocrinol. Metab. 290 (2006) E798-E807
56. Walle U.K., and Walle T. Transport of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer: role of efflux pumps. Carcinogenesis 20 (1999) 2153-2157
57. Yasuda S., Itagaki S., Hirano T., and Iseki K. Effects of sex hormones on regulation of ABCG2 expression in the placental cell line BeWo. J. Pharm. Pharm. Sci. 9 (2005) 133-139
58. Yeboah D., Sun M., Kingdom J., Baczyk D., Lye S.J., Matthews S.G., and Gibb W. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can. J. Physiol. Pharmacol. 84 (2006) 1251-1258
59. Zamudio S., Baumann M.U., and Illsley N.P. Effects of chronic hypoxia in vivo on the expression of human placental glucose transporters. Placenta 27 (2006) 49-55
60. Zhang Y., Wang H., Unadkat J.D., and Mao Q. Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. Drug Metab Dispos. 35 (2007) 2154-2158
61. Zheng W., Gustafson D.R., Sinha R., Cerhan J.R., Moore D., Hong C.P., Anderson K.E., Kushi L.H., Sellers T.A., and Folsom A.R. Well-done meat intake and the risk of breast cancer. J. Natl. Cancer Inst. 90 (1998) 1724-1729